Featured Research

from universities, journals, and other organizations

Use Of Novel Antipsychotic Shows Decreased Rehospitalization Rates, Lower Cost

Date:
December 12, 1997
Source:
University Of Maryland At Baltimore
Summary:
New findings by researchers from the University of Maryland show that patients treated with lower doses of the novel antipsychotic risperidone were rehospitalized less frequently than patients who received conventional antipsychotic treatment, thereby improving results and lowering costs.

Long-term outcomes for patients with schizophrenia have been disappointing. Treatment using conventional antipsychotics show high rates of recidivism which, in turn, is costly for the system. However, new findings by researchers from the University of Maryland show that patients treated with the novel antipsychotic risperidone (brand name Risperdalฎ) experienced a lower readmission rate than patients who received conventional antipsychotic treatment.

Related Articles


The study team, lead by Dr. Robert Conley, assistant professor of psychiatry at the University of Maryland School of Medicine, along with Dr. Raymond Love, director of the Mental Health Program at the University of Maryland School of Pharmacy, and Dr. Deanna Kelly, instructor at the School of Medicine, found that after one year, the rehospitalization rate for patients treated with risperidone for schizophrenia or schizoaffective disorder was 17 percent, which compares favorably to previously published rates of as high as 50 percent using conventional antipsychotics.

"This study shows that in a real-world setting, the benefits of novel antipsychotics include improvements in the patients’ quality of life and potential monetary savings," said Conley. "This evidence suggests that the higher cost of these novel agents can be made up for in terms of dollar savings from fewer readmissions."

In a separate but related study, Dr. Conley’s team analyzed risperidone dosing trends in schizophrenia patients within the Maryland Mental Health System between 1994 and 1996, the first such study in a large population. They determined that patients successfully discharged on risperidone were treated with significantly lower doses than those who remained hospitalized.

"The importance of establishing effective dosing regimens cannot be overstated," said Conley. "Patients who are under dosed or who receive excessive doses may fail to respond or could experience negative side-effects, which, in turn, could lead to drug discontinuation by clinicians or noncompliance by patients. Higher doses also may mean higher costs."

Love pointed out that another benefit of using lower doses of risperidone may be a decrease in costs per patient treated. In 1996, the cost for a patient receiving the average discharge dose of risperidone was approximately $1,900 compared to $2,450 for a patient receiving the average dose reported for those who remained hospitalized. Recent reports from Maryland’s Statewide Pharmacy and Therapeutics Committee show that the average daily dose of the antipsychotic olanzapine (brand name Zyprexaฎ) was $3,350 for discharged patients and $4,000 for those who remained hospitalized.

"Although the availability of a newer generation of antipsychotics has resulted in savings by reducing hospitalization, the higher costs of these medications may offset some of those savings," said Love. "This study shows that at least for risperidone, use of lower doses may produce better outcomes as well as reduce costs."


Story Source:

The above story is based on materials provided by University Of Maryland At Baltimore. Note: Materials may be edited for content and length.


Cite This Page:

University Of Maryland At Baltimore. "Use Of Novel Antipsychotic Shows Decreased Rehospitalization Rates, Lower Cost." ScienceDaily. ScienceDaily, 12 December 1997. <www.sciencedaily.com/releases/1997/12/971212094857.htm>.
University Of Maryland At Baltimore. (1997, December 12). Use Of Novel Antipsychotic Shows Decreased Rehospitalization Rates, Lower Cost. ScienceDaily. Retrieved October 24, 2014 from www.sciencedaily.com/releases/1997/12/971212094857.htm
University Of Maryland At Baltimore. "Use Of Novel Antipsychotic Shows Decreased Rehospitalization Rates, Lower Cost." ScienceDaily. www.sciencedaily.com/releases/1997/12/971212094857.htm (accessed October 24, 2014).

Share This



More Mind & Brain News

Friday, October 24, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Academic Scandal Shocks UNC

Academic Scandal Shocks UNC

AP (Oct. 23, 2014) — A scandal involving bogus classes and inflated grades at the University of North Carolina was bigger than previously reported, a new investigation found. (Oct. 23) Video provided by AP
Powered by NewsLook.com
Working Mother Getaway: Beaches Turks & Caicos

Working Mother Getaway: Beaches Turks & Caicos

Working Mother (Oct. 22, 2014) — Feast your eyes on this gorgeous family-friendly resort. Video provided by Working Mother
Powered by NewsLook.com
What Your Favorite Color Says About You

What Your Favorite Color Says About You

Buzz60 (Oct. 22, 2014) — We all have one color we love to wear, and believe it or not, your color preference may reveal some of your character traits. In celebration of National Color Day, Krystin Goodwin (@kyrstingoodwin) highlights what your favorite colors may say about you. Video provided by Buzz60
Powered by NewsLook.com
First-Of-Its-Kind Treatment Gives Man Ability To Walk Again

First-Of-Its-Kind Treatment Gives Man Ability To Walk Again

Newsy (Oct. 21, 2014) — A medical team has for the first time given a man the ability to walk again after transplanting cells from his brain onto his severed spinal cord. Video provided by Newsy
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
 
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:  

Breaking News:

Strange & Offbeat Stories

 

Health & Medicine

Mind & Brain

Living & Well

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:  

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile iPhone Android Web
Follow Facebook Twitter Google+
Subscribe RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins